A Pilot Prospective, Randomized Controlled Trial Assessing the Clinical Impact of Integrated Pharmacogenetic Testing on Selected OASIS Metrics, Re-hospitalizations and Emergency Department Visits

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT02378220

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-28T10:37:34.569198+00:00

Published At

2018-08-29T00:00:00+00:00

Record Updated At

2019-09-20

Results Posted At

2018-08-29

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Adverse Drug Events", "Adverse Drug Reactions", "Drug Interaction Potentiation", "Drug Metabolism, Poor, CYP2D6-RELATED", "Drug Metabolism, Poor, CYP2C19-RELATED", "Cytochrome P450 Enzyme Deficiency", "Cytochrome P450 CYP2D6 Enzyme Deficiency", "Cytochrome P450 CYP2C9 Enzyme Deficiency", "Cytochrome P450 CYP2C19 Enzyme Deficiency", "Cytochrome P450 CYP3A Enzyme Deficiency", "Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant", "Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant", "Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2019-09-20"

protocolSection.identificationModule.nctId

"NCT02378220"

protocolSection.identificationModule.officialTitle

"A Pilot Prospective, Randomized Controlled Trial Assessing the Clinical Impact of Integrated Pharmacogenetic Testing on Selected OASIS Metrics, Re-hospitalizations and Emergency Department Visits"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2018-08-29"

Study condition terms

• Adverse Drug Events (protocolSection.conditionsModule.conditions)
• Adverse Drug Reactions (protocolSection.conditionsModule.conditions)
• Drug Interaction Potentiation (protocolSection.conditionsModule.conditions)
• Drug Metabolism, Poor, CYP2D6-RELATED (protocolSection.conditionsModule.conditions)
• Drug Metabolism, Poor, CYP2C19-RELATED (protocolSection.conditionsModule.conditions)
• Cytochrome P450 Enzyme Deficiency (protocolSection.conditionsModule.conditions)
• Cytochrome P450 CYP2D6 Enzyme Deficiency (protocolSection.conditionsModule.conditions)
• Cytochrome P450 CYP2C9 Enzyme Deficiency (protocolSection.conditionsModule.conditions)
• Cytochrome P450 CYP2C19 Enzyme Deficiency (protocolSection.conditionsModule.conditions)
• Cytochrome P450 CYP3A Enzyme Deficiency (protocolSection.conditionsModule.conditions)
• Poor Metabolizer Due to Cytochrome P450 CYP2C9 Variant (protocolSection.conditionsModule.conditions)
• Poor Metabolizer Due to Cytochrome p450 CYP2C19 Variant (protocolSection.conditionsModule.conditions)
• Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.